InDevR Raises $7 million in Series A Financing with Adjuvant Capital

InDevR Raises $7 million in Series A Financing with Adjuvant [...]

InDevR Raises $7 million in Series A Financing with Adjuvant Capitalrodriguez2021-01-05T11:22:15-07:00

ESACT 2017

InDevR was represented at the ESACT 2017 meeting, May 14-17 [...]

ESACT 2017InDevR Admin2021-01-05T11:35:04-07:00

VaxArray Study Published in Vaccine

VaxArray Flu Vaccine Potency Study Published in Vaccine InDevR’s Study, [...]

VaxArray Study Published in VaccineInDevR Admin2021-01-05T11:35:32-07:00

BIO 2016

InDevR is exhibited in booth 5583 in the BioProcess Zone at the BIO [...]

BIO 2016InDevR Admin2020-10-23T14:26:51-06:00

Vaccines R&D-2015

Dr. Kathy Rowlen presented the latest data for VaxArray Influenza at the [...]

Vaccines R&D-2015InDevR Admin2020-10-23T14:27:26-06:00